• Western blot analysis of lysates from COLO and NIH/3T3 cells, using APOOL Antibody. The lane on the right is blocked with the synthesized peptide.
  • Western blot analysis of SH-SY5Y 293T 3T3 lysis using ApoOL antibody. Antibody was diluted at 1:1000

Anti-APOOL antibody (219-268 aa) (STJ91647)

SKU:
STJ91647

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-MICOS complex subunit MIC27 (219-268 aa) is suitable for use in Western Blot and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
ELISA 1:40000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: APOOL
Gene ID: 139322
Uniprot ID: MIC27_HUMAN
Immunogen Region: 219-268 aa
Specificity: ApoOL Polyclonal Antibody detects endogenous levels of ApoOL protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human APOOL at the amino acid range 219-268
Protein Name Micos Complex Subunit Mic27
Apolipoprotein O-Like
Protein Fam121a
Database Links Reactome: R-HSA-114608
Reactome: R-HSA-8949613
Cellular Localisation Mitochondrion Inner Membrane
Multi-Pass Membrane Protein
Mitochondrion
Alternative Antibody Names Anti-Micos Complex Subunit Mic27 antibody
Anti-Apolipoprotein O-Like antibody
Anti-Protein Fam121a antibody
Anti-APOOL antibody
Anti-CXorf33 antibody
Anti-FAM121A antibody
Anti-MIC27 antibody
Anti-UNQ8193 antibody
Anti-PRO23204 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance